Intel Capital led a $14.1m round for the cancer diagnostics system provider, its parent company having already supplied it with artificial intelligence technology.

Lonza participated in the gene therapy developer's series A round alongside Partners Innovation Fund, having also licensed technology to the startup.

General Catalyst led a $51m round for the Ascension-backed healthcare automation technology developer, which has now received $119m in total.

AristaMD, developer of a remote diagnostics system, raised $18m in a round co-led by Cigna Ventures and MemorialCare Innovation Fund.

IHH Healthcare participated in a series B round that boosted the care provider's capital base to more than $40m.

Hillhouse Capital and Chen Yi Investment are making a secondary investment in the Hualan Biological Engineering spinoff which is now valued at more than $1.9bn.

Avail Medsystems, a remote medical device startup which counts Baidu Ventures as an investor, has captured $15m in new funding.

The corporate owned a 15% stake in immunotherapy developer Lyell, which recently raised $493m, with a fair value of $203m as of the end of 2019.

Shiratronics added $3m from Breakout Ventures to a LivaNova-backed round that will support clinical development of its neuromodulation-based migraine treatment.

Takeda Ventures and Alexandria Venture Investments contributed to the $15.5m first close of the gene therapy developer's series A round.